Strategies to reduce renal risks associated with the use of contrast

Abstract

The use of contrast agents transformed diagnostic and therapeutic procedures, allowing for better internal visualisation. However, it also generated complications such as contrast-induced acute kidney injury (CI-AKI), especially in patients with risk factors such as chronic kidney disease, diabetes or heart failure. In Argentina, during 2024, the importance of evaluating patients before the use of contrast, adequate hydration and the use of low-osmolality agents was recognised. Strategies such as standardised protocols, medical training and monitoring were established to reduce the incidence of this complication. Prevention and equitable access to resources were key to improving renal health outcomes.